Saraq Hepatitis C kit receives CDSCO nod
Drug Approval

Saraq Hepatitis C kit receives CDSCO nod

The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth

  • By IPP Bureau | April 21, 2022

CoSara Diagnostics, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises and Co-Diagnostics, Salt Lake City, Utah, USA recently got permission to manufacture and sell its Saraq Hepatitis C viral load kit as an in vitro diagnostic from CDSCO.

The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth. Effective HCV treatments are especially useful when used in tandem with tests for diagnosing and monitoring those therapies. This HCV Viral Load kit test adds to our expanding menu of valuable diagnostic tools available to our growing distributor and laboratory customer base, the company said in a release. 

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International